Nelson Capital Management’s AbbVie ABBV Stock Holding History

Nelson Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.87M	Buy	23,345 +495	+2%	+$106K	0.64%	26
2026 Q1	$4.97M	Sell	22,850 -142	-0.6%	-$31.5K	0.61%	28
2025 Q4	$5.25M	Sell	22,992 -421	-2%	-$95.9K	0.61%	29
2025 Q3	$5.42M	Sell	23,413 -514	-2%	-$105K	0.65%	29
2025 Q2	$4.44M	Sell	23,927 -119	-0.5%	-$22.1K	0.59%	32
2025 Q1	$5.04M	Sell	24,046 -340	-1%	-$66.1K	0.87%	28
2024 Q4	$4.33M	Sell	24,386 -1,296	-5%	-$238K	0.72%	32
2024 Q3	$5.07M	Buy	25,682 +414	+2%	+$77.3K	0.85%	29
2024 Q2	$4.33M	Sell	25,268 -721	-3%	-$119K	0.77%	34
2024 Q1	$4.73M	Buy	25,989 +5,578	+27%	+$961K	0.9%	31
2023 Q4	$3.16M	Sell	20,411 -4,054	-17%	-$591K	0.71%	40
2023 Q3	$3.65M	Buy	24,465 +293	+1%	+$43K	0.89%	34
2023 Q2	$3.26M	Buy	24,172 +1,198	+5%	+$176K	0.84%	43
2023 Q1	$3.66M	Buy	22,974 +17,933	+356%	+$2.74M	1.04%	37
2022 Q4	$815K	Hold	5,041	–	–	0.24%	68
2022 Q3	$677K	Hold	5,041	–	–	0.2%	72
2022 Q2	$772K	Hold	5,041	–	–	0.21%	72
2022 Q1	$817K	Sell	5,041 -300	-6%	-$43.6K	0.16%	76
2021 Q4	$723K	Hold	5,341	–	–	0.13%	80
2021 Q3	$576K	Sell	5,341 -250	-4%	-$28.6K	0.11%	78
2021 Q2	$630K	Hold	5,591	–	–	0.13%	77
2021 Q1	$605K	Sell	5,591 -2,505	-31%	-$268K	0.13%	75
2020 Q4	$867K	Hold	8,096	–	–	0.19%	66
2020 Q3	$709K	Sell	8,096 -150	-2%	-$14.1K	0.12%	74
2020 Q2	$810K	Sell	8,246 -867	-10%	-$76.3K	0.18%	65
2020 Q1	$694K	Hold	9,113	–	–	0.19%	65
2019 Q4	$807K	Sell	9,113 -1,207	-12%	-$100K	0.17%	70
2019 Q3	$781K	Buy	10,320 +1,000	+11%	+$68.6K	0.19%	62
2019 Q2	$678K	Sell	9,320 -200	-2%	-$15.7K	0.16%	66
2019 Q1	$767K	Sell	9,520 -1,497	-14%	-$122K	0.19%	59
2018 Q4	$1.02M	Sell	11,017 -30	-0.3%	-$2.64K	0.28%	60
2018 Q3	$1.04M	Buy	11,047 +30	+0.3%	+$2.85K	0.24%	57
2018 Q2	$1.02M	Buy	11,017 +667	+6%	+$65.1K	0.26%	57
2018 Q1	$980K	Sell	10,350 -240	-2%	-$26.4K	0.25%	58
2017 Q4	$1.02M	Buy	10,590 +5,922	+127%	+$558K	0.32%	52
2017 Q3	$415K	Hold	4,668	–	–	0.14%	62
2017 Q2	$338K	Hold	4,668	–	–	0.11%	64
2017 Q1	$304K	Hold	4,668	–	–	0.1%	66
2016 Q4	$292K	Hold	4,668	–	–	0.1%	69
2016 Q3	$294K	Buy	4,668 +1,100	+31%	+$71.2K	0.1%	66
2016 Q2	$221K	Sell	3,568 -92	-3%	-$5.61K	0.08%	68
2016 Q1	$209K	Hold	3,660	–	–	0.08%	68
2015 Q4	$217K	Hold	3,660	–	–	0.08%	66
2015 Q3	$199K	Sell	3,660 -29	-0.8%	-$1.89K	0.08%	69
2015 Q2	$248K	Sell	3,689 -45	-1%	-$2.94K	0.09%	69
2015 Q1	$219K	Sell	3,734 -50	-1%	-$3.02K	0.08%	71
2014 Q4	$248K	Sell	3,784 -861	-19%	-$54.3K	0.09%	71
2014 Q3	$268K	Buy	4,645 +745	+19%	+$41.4K	0.1%	67
2014 Q2	$220K	Buy	3,900 +420	+12%	+$22K	0.09%	71
2014 Q1	$179K	Buy	3,480 +210	+6%	+$10.6K	0.08%	73
2013 Q4	$173K	Hold	3,270	–	–	0.08%	76
2013 Q3	$146K	Hold	3,270	–	–	0.07%	78
2013 Q2	$135K	Buy	+3,270	New	+$143K	0.07%	77

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Nelson Capital Management's ABBV Position: Q2 2026 in Review

Nelson Capital Management increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $106K and bringing the position to 23,345 shares worth $5.87M. The position accounts for 0.64% of the portfolio, ranked #26.

Nelson Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Nelson Capital Management held 23,345 shares of AbbVie worth $5.87M as of Q2 2026.
Nelson Capital Management bought 495 AbbVie shares in Q2 2026, an estimated $106K.
AbbVie made up 0.64% of Nelson Capital Management's portfolio in Q2 2026, its #26 holding.
Nelson Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nelson Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.